Literature DB >> 6219686

Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

C E Essed, M Van den Brand, A E Becker.   

Abstract

Transluminal coronary angioplasty was performed in a 51 year old man with a localised narrowing of the proximal segment of the left anterior descending coronary artery. Initial inflations with a small size balloon catheter were unsuccessful. A second attempt, during the same procedure, using a larger calibre catheter relieved the obstruction but produced a dissection. Angina pectoris reappeared approximately three months later. Another attempt to relieve the obstruction by angioplasty, five months after the initial procedure, induced ST segment elevation before angioplasty, followed by ventricular fibrillation and death. The necropsy showed a split in the pre-existent sclerotic plaque and a dissecting aneurysm of the media. A proliferation of fibrocellular tissue filled the false channel and almost totally occluded the pre-existent arterial lumen. The observation suggests that wall laceration with exposure of smooth muscle cells to blood may have initiated the excessive fibrocellular tissue response. This event may be the underlying pathogenetic mechanism for the occurrence of early restenosis after transluminal coronary angioplasty.

Entities:  

Mesh:

Year:  1983        PMID: 6219686      PMCID: PMC481320          DOI: 10.1136/hrt.49.4.393

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  [Percutaneous recanalisation of chronic arterial occlusions (Dotter principle) with a new double lumen dilatation catheter (author's transl)].

Authors:  A Grüntzig
Journal:  Rofo       Date:  1976-01

Review 2.  The pathogenesis of atherosclerosis (first of two parts).

Authors:  R Ross; J A Glomset
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

3.  Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

Authors:  K M Kent; L G Bentivoglio; P C Block; M J Cowley; G Dorros; A J Gosselin; A Gruntzig; R K Myler; J Simpson; S H Stertzer; D O Williams; L Fisher; M J Gillespie; K Detre; S Kelsey; S M Mullin; M B Mock
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

4.  Morphology after transluminal angioplasty in human beings.

Authors:  P C Block; R K Myler; S Stertzer; J T Fallon
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

5.  Transluminal coronary angioplasty of postmortem human hearts.

Authors:  K L Baughman; R C Pasternak; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

6.  Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries.

Authors:  R C Pasternak; K L Baughman; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1980-03       Impact factor: 2.778

7.  Experimental angioplasty: lessons from the laboratory.

Authors:  P C Block; J T Fallon; D Elmer
Journal:  AJR Am J Roentgenol       Date:  1980-11       Impact factor: 3.959

8.  Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.

Authors:  P C Block; K L Baughman; R C Pasternak; J T Fallon
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

9.  Evaluation of transluminal angioplasty of chronic coronary artery stenosis. Value and limitations assessed in fresh human cadaver hearts.

Authors:  G Lee; R M Ikeda; J A Joye; H G Bogren; A N DeMaria; D T Mason
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

10.  Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate.

Authors:  R B Rutherford; R Ross
Journal:  J Cell Biol       Date:  1976-04       Impact factor: 10.539

  10 in total
  24 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Restenosis following coronary angioplasty.

Authors:  K J Beatt; P W Serruys
Journal:  Int J Card Imaging       Date:  1990

3.  The Strecker stent: indications and results in iliac and femoropopliteal arteries.

Authors:  D Liermann; E P Strecker; J Peters
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

4.  Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study.

Authors:  S Tanizawa; M Ueda; C M van der Loos; A C van der Wal; A E Becker
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

5.  Laser ablation and the need for intra-arterial imaging.

Authors:  C Borst; R Rienks; W P Mali; L van Erven
Journal:  Int J Card Imaging       Date:  1989

6.  Intravascular echographic assessment of vessel wall characteristics: a correlation with histology.

Authors:  W J Gussenhoven; C E Essed; P Frietman; F Mastik; C Lancée; C Slager; P Serruys; P Gerritsen; H Pieterman; N Bom
Journal:  Int J Card Imaging       Date:  1989

Review 7.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 8.  Cell culture systems to study progression and inhibition of intimal proliferations.

Authors:  E Betz
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

9.  Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.

Authors:  J T Willerson; S K Yao; J McNatt; C R Benedict; H V Anderson; P Golino; S S Murphree; L M Buja
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 10.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.